Axcella Health, Inc. is a biotechnology company. It engages in the research and development of treatment for diseases and improves health using endogenous metabolic modulator, or EMM, and compositions. Its product pipeline includes AXA1665, for the reduction in risk of recurrent overt hepatic encephalopathy, and AXA1125, for non-alcoholic steatohepatitis. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn, and David A. Berry on August 27, 2008 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Axcella Health Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Axcella Health Inc market cap is $1.18M.
What is the 52-week high for Axcella Health Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Axcella Health Inc 52 week high is $41.25 as of September 17, 2025.
What is the 52-week low for Axcella Health Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Axcella Health Inc 52 week low is $0.34 as of September 17, 2025.
What is Axcella Health Inc stock price today?
Axcella Health Inc stock price today is $0.4009.
What was Axcella Health Inc stock price yesterday?
Axcella Health Inc stock price yesterday was $0.44.
What is the PE ratio of Axcella Health Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Axcella Health Inc’s P/E ratio is -0.02.
What is the Price-to-Book ratio of Axcella Health Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Axcella Health Inc P/B ratio is -0.5234.
What is Axcella Health Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Axcella Health Inc's EBITDA is -0.21.
What is the 50-day moving average of Axcella Health Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Axcella Health Inc 50-day moving average is $3.38.
